This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Fourth View: Understanding the progression of antibiotic resistance, the development of new antibiotics, and the potential of the PASTEUR Act which has been introduced to Congress.

Ticker(s): IBB

Who's the expert?

  • comfortable discussing the current landscape and concerns regarding antibiotic resistance.
  • As a hospitalist sees and admits many patients and often makes decisions based on prior cultures that very frequently show significant resistance.
  • Reviewed the PASTEUR ACT

Interview Questions
Q1.

What is the current state of treatments with new resistance developing?

Added By: max_admin
Q2.

On a scale of 1-10 how excited are you regarding the PASTEUR act?

Added By: max_admin
Q3.

What hurdles do you see companies running into in developing new antibiotics?

Added By: max_admin

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.